| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.24 | 0.005 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |